|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848194
Online Users : 853
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/11642
|
Title: | Cordycepin suppresses endothelial cell proliferation, migration, angiogenesis, and tumor growth by regulating focal adhesion kinase and p53 |
Authors: | Lin, YT;Liang, SM;Wu, YJ;Wu, YJ;Lu, YJ;Jan, YJ;Ko, BS;Chuang, YJ;Shyue, SK;Kuo, CC;Liou, JY |
Contributors: | Institute of Cellular and Systems Medicine |
Abstract: | Focal adhesion kinase (FAK) plays an important role in vascular development, including the regulation of endothelial cell (EC) adhesion, migration, proliferation, and survival. 3'-deoxyadenosine (cordycepin) is known to suppress FAK expression, cell migration, and the epithelial(-)mesenchymal transition in hepatocellular carcinoma (HCC). However, whether cordycepin affects FAK expression and cellular functions in ECs and the specific molecular mechanism remain unclear. In this study, we found that cordycepin suppressed FAK expression and the phosphorylation of FAK (p-FAK) at Tyr397 in ECs. Cordycepin inhibited the proliferation, wound healing, transwell migration, and tube formation of ECs. Confocal microscopy revealed that cordycepin significantly reduced FAK expression and decreased focal adhesion number of ECs. The suppressed expression of FAK was accompanied by induced p53 and p21 expression in ECs. Finally, we demonstrated that cordycepin suppressed angiogenesis in an in vivo angiogenesis assay and reduced HCC tumor growth in a xenograft nude mice model. Our study indicated that cordycepin could attenuate cell proliferation and migration and may result in the impairment of the angiogenesis process and tumor growth via downregulation of FAK and induction of p53 and p21 in ECs. Therefore, cordycepin may be used as a potential adjuvant for cancer therapy. |
Date: | 2019-02-01 |
Relation: | Cancers. 2019 Feb 1;11(2):Article number 168. |
Link to: | http://dx.doi.org/10.3390/cancers11020168 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2072-6694&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000460747200042 |
Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85062407610 |
Appears in Collections: | [Jun-Yang Liou] Periodical Articles [Cheng-Chin Kuo] Periodical Articles
|
Files in This Item:
File |
Description |
Size | Format | |
PUB30717276.pdf | | 5355Kb | Adobe PDF | 481 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|